144 related articles for article (PubMed ID: 37510121)
1. Multiparametric Contrast-Enhanced Ultrasound in Early Prediction of Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival in Breast Cancer.
Wan C; Zhou L; Li H; Wang L; Li F; Yin W; Wang Y; Jiang L; Lu J
Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510121
[TBL] [Abstract][Full Text] [Related]
2. Strain ultrasonic elastography imaging features of locally advanced breast cancer: association with response to neoadjuvant chemotherapy and recurrence-free survival.
Wan C; Zhou L; Jin Y; Li F; Wang L; Yin W; Wang Y; Li H; Jiang L; Lu J
BMC Med Imaging; 2023 Dec; 23(1):216. PubMed ID: 38129778
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer.
Peng J; Pu H; Jia Y; Chen C; Ke XK; Zhou Q
Medicine (Baltimore); 2021 May; 100(19):e25908. PubMed ID: 34106653
[TBL] [Abstract][Full Text] [Related]
4. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
[TBL] [Abstract][Full Text] [Related]
5. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
6. Dual-Branch Convolutional Neural Network Based on Ultrasound Imaging in the Early Prediction of Neoadjuvant Chemotherapy Response in Patients With Locally Advanced Breast Cancer.
Xie J; Shi H; Du C; Song X; Wei J; Dong Q; Wan C
Front Oncol; 2022; 12():812463. PubMed ID: 35463368
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
8. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound.
Huang Y; Le J; Miao A; Zhi W; Wang F; Chen Y; Zhou S; Chang C
Gland Surg; 2021 Apr; 10(4):1280-1290. PubMed ID: 33968680
[TBL] [Abstract][Full Text] [Related]
9. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
10. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
11. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
12. Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Che S; Zhao X; Ou Y; Li J; Wang M; Wu B; Zhou C
Medicine (Baltimore); 2016 Jan; 95(4):e2420. PubMed ID: 26825883
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
Sharma A; Grover SB; Mani C; Ahluwalia C
Br J Radiol; 2021 May; 94(1121):20201160. PubMed ID: 33860674
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of contrast-enhanced ultrasonography and strain elastography of locally advanced breast cancer.
Gu LS; Zhang R; Wang Y; Liu XM; Ma F; Wang JY; Sun XY; Liu MJ; Wang B; Zou SM
J Thorac Dis; 2019 Dec; 11(12):5274-5289. PubMed ID: 32030245
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Strain Elastography and Contrast-Enhanced Ultrasound in Predicting the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: A Nomogram Integrating Ki-67 and Ultrasound Features.
Liu Q; Tang L; Chen M
J Ultrasound Med; 2022 Sep; 41(9):2191-2201. PubMed ID: 34888900
[TBL] [Abstract][Full Text] [Related]
16. High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer.
Kogawa T; Fouad TM; Liu DD; Wu J; Shen Y; Masuda H; Fujii T; Chavez-MacGregor M; Alvarez RH; Hortobágyi GN; Valero V; Ueno NT
Oncologist; 2016 Jan; 21(1):21-7. PubMed ID: 26659222
[TBL] [Abstract][Full Text] [Related]
17. Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the axillary lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients.
Han X; Jin S; Yang H; Zhang J; Huang Z; Han J; He C; Guo H; Yang Y; Shan M; Zhang G
Br J Radiol; 2021 Sep; 94(1125):20210520. PubMed ID: 34415197
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the response of breast cancer patients to neoadjuvant chemotherapy by combined contrast-enhanced ultrasonography and ultrasound elastography.
Wang B; Jiang T; Huang M; Wang J; Chu Y; Zhong L; Zheng S
Exp Ther Med; 2019 May; 17(5):3655-3663. PubMed ID: 30988749
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
